Cargando…

Maturation of coagulation factor IX during Xase formation as deduced using factor VIII‐derived peptides

Blood coagulation involves extrinsic and intrinsic pathways, which merge at the activation step of blood coagulation factor X to factor Xa. This step is catalysed by the extrinsic or intrinsic Xase, which consists of a complex of factor VIIa and its cofactor tissue factor or factor IXa (FIXa) and it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Han, Zögg, Thomas, Brandstetter, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668378/ https://www.ncbi.nlm.nih.gov/pubmed/31077577 http://dx.doi.org/10.1002/2211-5463.12653

Ejemplares similares

Modified Factor VIII and Factor IX recombinant products
por: Santagostino, Elena, et al.
Publicado: (2018)

Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity
por: Zhao, Ying, et al.
Publicado: (2017)

Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII
por: van Haren, Simon D., et al.
Publicado: (2013)

Compensated pathogenic variants in coagulation factors VIII and IX present complex mapping between molecular impact and hemophilia severity
por: Marín, Òscar, et al.
Publicado: (2019)

FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIES
por: Zimmerman, Theodore S., et al.
Publicado: (1973)

Augmented Degradation of Factors VIII and IX in the Intermittent Movement State
por: Cohen, Haim, et al.
Publicado: (2023)

Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments
por: Bowyer, Annette E., et al.
Publicado: (2022)

Coagulation Factor IX for Hemophilia B Therapy 
por: Orlova, N. A., et al.
Publicado: (2012)

Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX
por: Rocino, Angiola, et al.
Publicado: (2017)

Development and Characterization of Recombinant Ovine Coagulation Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2012)

Bacterial Production of Recombinant Coagulation Factor VIII Domains
por: Bashar, Saima, et al.
Publicado: (2023)

Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX
por: Yoo, Ki-Young, et al.
Publicado: (2018)

The traceability of commercial plasma calibrators to the plasma International Standards for factor VIII and factor IX
por: Wilmot, Helen V., et al.
Publicado: (2020)

Therapeutic Effects of Kefir Peptides on Hemophilia-Induced Osteoporosis in Mice With Deficient Coagulation Factor VIII
por: Yen, Chih-Ching, et al.
Publicado: (2022)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

Red Blood Cells are Appropriate Carrier for Coagulation Factor VIII
por: Sayyadipour, Fatemeh, et al.
Publicado: (2020)

Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes
por: Dalm, Daniela, et al.
Publicado: (2015)

Human coagulation factor VIII domain-specific recombinant polypeptide expression
por: Choi, Su Jin, et al.
Publicado: (2015)

Study on Coagulation Factor VIII and Fibrinogen Levels in Patients with Thyroid Disorders
por: Thoyyib, Muhammed, et al.
Publicado: (2018)

Identification of Key Coagulation Activity Determining Elements in Canine Factor VIII
por: Firrman, Jenni, et al.
Publicado: (2020)

Exploring the Complex Role of Coagulation Factor VIII in Chronic Liver Disease
por: Pradhan-Sundd, Tirthadipa, et al.
Publicado: (2021)

Characterization and visualization of murine coagulation factor VIII-producing cells in vivo
por: Hayakawa, Morisada, et al.
Publicado: (2021)

Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report
por: Doma, Saša Anžej, et al.
Publicado: (2016)

Probing activation‐driven changes in coagulation factor IX by mass spectrometry
por: Freato, Nadia, et al.
Publicado: (2021)

Lacerations to Zones VIII and IX: It Is Not Just a Tendon Injury
por: Fischer, Charla R., et al.
Publicado: (2011)

Further Data on the Stanford-Binet VIII- and IX-Year Tests
por: Wallin, J. E. Wallace
Publicado: (1933)

Structure of coagulation factor VIII bound to a patient-derived anti–C1 domain antibody inhibitor
por: Childers, Kenneth C., et al.
Publicado: (2023)

Molecular Analysis of Factor VIII and Factor IX Genes in Hemophilia Patients: Identification of Novel Mutations and Molecular Dynamics Studies
por: Al-Allaf, Faisal A., et al.
Publicado: (2017)

PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
por: Koyun, Derya, et al.
Publicado: (2023)

Detection of Fibrinogen and Coagulation Factor VIII in Plasma by a Quartz Crystal Microbalance Biosensor
por: Yao, Chunyan, et al.
Publicado: (2013)

Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma
por: Ping, Zheng, et al.
Publicado: (2017)

Protein residue network analysis reveals fundamental properties of the human coagulation factor VIII
por: Lopes, Tiago J. S., et al.
Publicado: (2021)

Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review
por: Bosch, Alessandra, et al.
Publicado: (2023)

Discharged. Not Where to Lay His Head: Chapters VII, VIII, IX
por: Fleming, George
Publicado: (1886)

The first EGF domain of coagulation factor IX attenuates cell adhesion and induces apoptosis
por: Ishikawa, Tomomi, et al.
Publicado: (2016)

Ribosome profiling of HEK293T cells overexpressing codon optimized coagulation factor IX
por: Alexaki, Aikaterini, et al.
Publicado: (2020)

Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report
por: Ren, Shou-Chen, et al.
Publicado: (2016)

Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels
por: Kiouptsi, Klytaimnistra, et al.
Publicado: (2017)

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
por: Pablo-Moreno, Juan A. De, et al.
Publicado: (2022)

The prevalence of anti-factor VIII and anti-factor IX antibodies among patients with hemophilia in Rabat, Morocco: a single center experience
por: Bouyadmar, Meryem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2m4li4h3ki4sefuc27e3c32hfl